The Acknowledgements section in this Article is incomplete:
“We are grateful to Hans Rosén and Per Hagmar (Vivolux AB) for discussions and study support and to Marina Ciomei (Accelera, Nerviano, Italy) for performance of animal studies. We are grateful to Ingrid Holmberg for artwork. We acknowledge Cancerfonden, Radiumhemmets forskningsfonder, Vetenskapsrådet, Barncancerfonden for support.”
should read:
“We are grateful to Hans Rosén and Per Hagmar (Vivolux AB) for discussions and study support and to Marina Ciomei (Accelera, Nerviano, Italy) for performance of animal studies. We are grateful to Ingrid Holmberg for artwork. We acknowledge Cancerfonden, Radiumhemmets forskningsfonder, Vetenskapsrådet, Barncancerfonden for support. We would like to acknowledge support from the Mayo Clinic Multiple Myeloma SPORE (P50 CA186781-01A1, Aneel Paulus) and the University of Iowa/Mayo Clinic Lymphoma SPORE (P50 CA097274, Aneel Paulus)”.
Additional information
The online version of the original article can be found at 10.1038/srep26979
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Wang, X., Mazurkiewicz, M., Hillert, EK. et al. Correction: Corrigendum: The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells. Sci Rep 6, 30667 (2016). https://doi.org/10.1038/srep30667
Published:
DOI: https://doi.org/10.1038/srep30667
This article is cited by
-
Targeting deubiquitinating enzymes in cancer stem cells
Cancer Cell International (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
